Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A new online clinical support tool called Anatool is helping emergency providers quickly identify and treat anaphylaxis. Developed by Food Allergy Research & Education (FARE), the tool walks clinicians through step-by-step diagnosis and epinephrine dosing based on 2024 international consensus guidelines. It's designed for emergency physicians, paramedics, nurses, and urgent care clinicians who need fast, evidence-based guidance at the bedside.
Anaphylaxis is a life-threatening emergency — and it's frequently mismanaged. A new online tool called Anatool, developed by Food Allergy Research & Education (FARE) in collaboration with Cincinnati Children's Hospital, aims to fix that by putting evidence-based guidance directly in clinicians' hands. Built on 2024 international consensus recommendations, the tool helps emergency physicians, paramedics, nurses, and urgent care providers quickly determine whether a patient is experiencing anaphylaxis and guides them through treatment — including epinephrine dosing and reassessment timers.
The tool works by prompting users to select the type of allergen exposure, then walks them through relevant symptoms to assess the likelihood of anaphylaxis. It includes weight-based dosing calculators, instructions for both intramuscular and intranasal epinephrine, and special criteria for infants and toddlers — a first in any consensus-based tool. Crucially, it never overrides clinical judgment; it flags reactions as "likely" or "unlikely" and always defers the final call to the treating clinician.
By the Numbers:
Why it matters: Epinephrine is dramatically underused in anaphylaxis — often because clinicians rely on oversimplified or outdated criteria. Anatool bridges the gap between published evidence and real-world practice, potentially improving outcomes by getting the right treatment to patients faster.
